Literature DB >> 16302983

Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive, and babA2-positive genotype in erosive reflux esophagitis disease.

Chih-Ho Lai1, Sek-Kwong Poon, Yun-Chu Chen, Chi-Sen Chang, Wen-Ching Wang.   

Abstract

BACKGROUND: Increased prevalence of esophagitis has been recognized in the West. Helicobacter pylori infection, particularly virulent strains, is proposed as a protective factor against the development of gastroesophageal reflux disease. To evaluate the relationship of reflux esophagitis with virulent H. pylori infection, we studied the prevalence of reflux esophagitis among H. pylori-infected and -uninfected patients and the genotype of isolates in Taiwan.
METHODS: Patients who had routine physical examination were investigated. The severity of esophagitis was evaluated using the Los Angeles grading system. H. pylori status was assessed by histology, rapid urease test, and bacterial culture. Genotyping of vacA, cagA, and babA2 was determined by polymerase chain reaction (PCR). Risk factors for severe esophagitis were evaluated.
RESULTS: Reflux esophagitis was found in 21.2% of 1622 patients. The prevalence of H. pylori infection was found in 33.0% of 276 patients with reflux esophagitis compared with 67.5% of 378 patients with normal esophagus (p < .001). Esophagitis occurred in a significantly lower rate among H. pylori-positive patients with peptic ulcer than those without peptic ulcer. cagA, babA2, and vacAs1a were detected in 100% of 143 isolates. Factors that predicted severe esophagitis included age, gender, and hiatus hernia but not H. pylori infection.
CONCLUSIONS: Our study suggests significantly lower incidence of H. pylori infection with the triple-positive virulent genotype in patients with reflux esophagitis in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302983     DOI: 10.1111/j.1523-5378.2005.00363.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  6 in total

Review 1.  Does Helicobacter pylori infection protect against esophageal diseases in Asia?

Authors:  Justin C Y Wu
Journal:  Indian J Gastroenterol       Date:  2011-08-26

2.  Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome.

Authors:  Saori Fujimoto; Olabisi Olaniyi Ojo; Anna Arnqvist; Jeng Yih Wu; Stefan Odenbreit; Rainer Haas; David Y Graham; Yoshio Yamaoka
Journal:  Clin Gastroenterol Hepatol       Date:  2006-12-06       Impact factor: 11.382

Review 3.  Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis.

Authors:  Yoshio Yamaoka
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

4.  Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship?

Authors:  Uday C Ghoshal; Dipti Chourasia
Journal:  J Neurogastroenterol Motil       Date:  2010-07-27       Impact factor: 4.924

5.  Statin Decreases Helicobacter pylori Burden in Macrophages by Promoting Autophagy.

Authors:  Wei-Chih Liao; Mei-Zi Huang; Michelle Lily Wang; Chun-Jung Lin; Tzu-Li Lu; Horng-Ren Lo; Yi-Jiun Pan; Yu-Chen Sun; Min-Chuan Kao; Hui-Jing Lim; Chih-Ho Lai
Journal:  Front Cell Infect Microbiol       Date:  2017-01-17       Impact factor: 5.293

6.  Mixed Infections of Helicobacter pylori Isolated from Patients with Gastrointestinal Diseases in Taiwan.

Authors:  Chih-Ho Lai; Ju-Chun Huang; Chuan Chiang-Ni; Ju-Pi Li; Lii-Tzu Wu; Hua-Shan Wu; Yu-Chen Sun; Mei-Ling Lin; Ju-Fang Lee; Hwai-Jeng Lin
Journal:  Gastroenterol Res Pract       Date:  2016-09-22       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.